# Onconetix, Inc.: Form 8-K, filed Mar 24, 2026

- Company: [Onconetix, Inc.](/companies/onco.md) (CIK 1782107)
- Form: 8-K
- Filed: 2026-03-24
- Accepted by EDGAR: Mar 24, 2026, 17:20 ET
- Period: 2026-03-18
- Accession: 0001213900-26-033643
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1782107/000121390026033643/ea0283046-8k_onconetix.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782107/000121390026033643/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782107/000121390026033643/ea0283046-8k_onconetix.htm

Filed Mar 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-033643. Last ingested by Listed: Oct 27, 2026, 08:32 ET. No prices; not investment advice.
